Historical Valuation
BioLife Solutions Inc (BLFS) is now in the Fair zone, suggesting that its current forward PS ratio of 10.86 is considered Fairly compared with the five-year average of -292.15. The fair price of BioLife Solutions Inc (BLFS) is between 12.89 to 24.74 according to relative valuation methord.
Relative Value
Fair Zone
12.89-24.74
Current Price：24.63
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
BioLife Solutions Inc (BLFS) has a current Price-to-Book (P/B) ratio of 3.24. Compared to its 3-year average P/B ratio of 2.86 , the current P/B ratio is approximately 13.28% higher. Relative to its 5-year average P/B ratio of 3.09, the current P/B ratio is about 4.69% higher. BioLife Solutions Inc (BLFS) has a Forward Free Cash Flow (FCF) yield of approximately 0.87%. Compared to its 3-year average FCF yield of -1.23%, the current FCF yield is approximately -171.21% lower. Relative to its 5-year average FCF yield of -1.50% , the current FCF yield is about -158.21% lower.
P/B
Median3y
2.86
Median5y
3.09
FCF Yield
Median3y
-1.23
Median5y
-1.50
Competitors Valuation Multiple
AI Analysis for BLFS
The average P/S ratio for BLFS competitors is 6.36, providing a benchmark for relative valuation. BioLife Solutions Inc Corp (BLFS.O) exhibits a P/S ratio of 10.86, which is 70.74% above the industry average. Given its robust revenue growth of 31.21%, this premium appears sustainable.
Performance Decomposition
AI Analysis for BLFS
1Y
3Y
5Y
Market capitalization of BLFS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BLFS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is BLFS currently overvalued or undervalued?
BioLife Solutions Inc (BLFS) is now in the Fair zone, suggesting that its current forward PS ratio of 10.86 is considered Fairly compared with the five-year average of -292.15. The fair price of BioLife Solutions Inc (BLFS) is between 12.89 to 24.74 according to relative valuation methord.
What is BioLife Solutions Inc (BLFS) fair value?
BLFS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of BioLife Solutions Inc (BLFS) is between 12.89 to 24.74 according to relative valuation methord.
How does BLFS's valuation metrics compare to the industry average?
The average P/S ratio for BLFS's competitors is 6.36, providing a benchmark for relative valuation. BioLife Solutions Inc Corp (BLFS) exhibits a P/S ratio of 10.86, which is 70.74% above the industry average. Given its robust revenue growth of 31.21%, this premium appears sustainable.
What is the current P/B ratio for BioLife Solutions Inc (BLFS) as of Jan 09 2026?
As of Jan 09 2026, BioLife Solutions Inc (BLFS) has a P/B ratio of 3.24. This indicates that the market values BLFS at 3.24 times its book value.
What is the current FCF Yield for BioLife Solutions Inc (BLFS) as of Jan 09 2026?
As of Jan 09 2026, BioLife Solutions Inc (BLFS) has a FCF Yield of 0.87%. This means that for every dollar of BioLife Solutions Inc’s market capitalization, the company generates 0.87 cents in free cash flow.
What is the current Forward P/E ratio for BioLife Solutions Inc (BLFS) as of Jan 09 2026?
As of Jan 09 2026, BioLife Solutions Inc (BLFS) has a Forward P/E ratio of 411.90. This means the market is willing to pay $411.90 for every dollar of BioLife Solutions Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for BioLife Solutions Inc (BLFS) as of Jan 09 2026?
As of Jan 09 2026, BioLife Solutions Inc (BLFS) has a Forward P/S ratio of 10.86. This means the market is valuing BLFS at $10.86 for every dollar of expected revenue over the next 12 months.